Neurobiological Markers for ADHD Diagnosis

Plain-language summary

Research suggests that while there is ongoing exploration into neurobiological markers for ADHD, especially in children, pinpointing definitive diagnostic tools is still a developing area. Some studies highlight specific brain functions and stress responses as potential indicators, but the overall evidence for precise, objective diagnostic markers remains mixed and requires further investigation.

Key findings

• One meta-analysis indicates potential links between ADHD in children and how their bodies manage stress, specifically involving the hypothalamic-pituitary-adrenal axis.
• A systematic review suggests that personalized medicine, including looking at certain brain patterns and genetics, might help in diagnosing ADHD in children more accurately, though more research is needed.
• Some studies are exploring how brain activity patterns, particularly those related to stopping impulses, could be different in young people with ADHD who are not on medication.

Studies cited (8)

1. Hypothalamic-pituitary-adrenal axis dysfunction in children with ADHD: A systematic review and meta-analysis — Fulun L, Yanan L, Bing G (2025, Psychoneuroendocrinology, meta-analysis)

   DOI: 10.1016/j.psyneuen.2025.107605

2. Precision Medicine in Pediatric Attention-deficit/Hyperactivity Disorder: A Systematic Review of Behavioral, Neurobiological and Genetic Diagnostic Biomarkers — Pranjić M, Peisch V, Vukšić N (2025, Journal of developmental and behavioral pediatrics : JDBP, systematic-review)

   DOI: 10.1097/DBP.0000000000001403

3. PET Imaging in Psychiatric Disorders — Ferrando R, Hernandes D, Ghini BG (2025, Seminars in nuclear medicine, other)

   DOI: 10.1053/j.semnuclmed.2025.06.004

4. Response inhibition deficits in unmedicated youth with ADHD: An ERP/sLORETA study — Xu Y, Zeng Y, Yin W (2025, Journal of affective disorders, other)

   DOI: 10.1016/j.jad.2025.119880

5. Individualized functional connectome identified generalizable biomarkers for psychiatric symptoms in transdiagnostic patients — Li M, Dahmani L, Hubbard CS (2023, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, other)

   DOI: 10.1038/s41386-022-01500-4 PMCID: PMC9938230

6. Advances, challenges, and promises in pediatric neuroimaging of neurodevelopmental disorders — Bednarz HM, Kana RK (2018, Neuroscience and biobehavioral reviews, other)

   DOI: 10.1016/j.neubiorev.2018.03.025

7. Pattern classification of response inhibition in ADHD: toward the development of neurobiological markers for ADHD — Hart H, Chantiluke K, Cubillo AI (2014, Human brain mapping, other)

   DOI: 10.1002/hbm.22386 PMCID: PMC4190683

8. Biomarkers for attention-deficit/hyperactivity disorder (ADHD). A consensus report of the WFSBP task force on biological markers and the World Federation of ADHD — Thome J, Ehlis AC, Fallgatter AJ (2012, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry, other)

   DOI: 10.3109/15622975.2012.690535